Free shipping on all orders over $ 500

Insulin degludec

Cat. No. M22472

All AbMole products are for research use only, cannot be used for human consumption.

Insulin degludec Structure
Size Price Availability Quantity
5mg USD 220 In stock
10mg USD 350 In stock
25mg USD 680 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Insulin degludec is an ultra-long-acting form of insulin, shows binding efficiency with an IC50 value of 19.59 nM/L for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.

Insulin degludec (200 nM; 10 min) increases glucose uptake in HL-1 cells.

In vivo, Insulin degludec (5 U/kg; s.c. once daily for 30 days) affects glucose homeostasis and liver metabolism in diabetic mice undergoing insulin-induced hypoglycemia.

Chemical Information
Molecular Weight 6103.97
Formula C274H411N65O81S6
CAS Number 844439-96-9
Form Solid
Storage -20°C, protect from light, dry, sealed
References

[1] Amalia Gastaldelli, et al. Lancet Diabetes Endocrinol. Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial

[2] Tadej Battelino, et al. Lancet Diabetes Endocrinol. Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial

[3] Ronald M Goldenberg, et al. Diabetes Obes Metab. Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia

[4] Roopa Mehta, et al. Diabetes Obes Metab. Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines

Related Insulin Receptor Products
KU14R

KU14R is a new I(3)-R antagonist that selectively blocks the insulin secretory response to imidazolines.

Kaempferitrin

Kaempferitrin is a natural flavonoid glycoside with pain relief, anti-inflammatory, anti-diabetes, anti-tumor and other effects, and can activate insulin signaling.

Rhoifolin

RhoifolinRhoifolin is a flavonoid glycoside isolated from the leaves of Guanxi pomelo (Citrus Grandis). Rhoifolin is beneficial to diabetic complications by enhancing adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and translocation of GLUT4. Rhoifolin ameliorates titanium-stimulated osteolysis and attenuates osteoclast formation through ranKL-induced NF-κB and MAPK pathways.

Demethylasterriquinone B1

Demethylasterriquinone B1 is a selective insulin RTK activator.

S961 TFA

S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 of 0.048 for HIR-A, HIR-B and higF-IR, respectively. 0.027 and 630 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Insulin degludec supplier, Insulin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.